HighTide Therapeutics Statistics
Total Valuation
HTTIF has a market cap or net worth of 188.57 million. The enterprise value is 147.38 million.
| Market Cap | 188.57M |
| Enterprise Value | 147.38M |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 571.33M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +26.18% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 2.75% |
| Owned by Institutions (%) | 4.87% |
| Float | 295.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.67 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.63 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.42 |
Financial Position
The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.27.
| Current Ratio | 3.44 |
| Quick Ratio | 3.03 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.42 |
| Interest Coverage | -123.53 |
Financial Efficiency
Return on equity (ROE) is -62.13% and return on invested capital (ROIC) is -39.07%.
| Return on Equity (ROE) | -62.13% |
| Return on Assets (ROA) | -35.29% |
| Return on Invested Capital (ROIC) | -39.07% |
| Return on Capital Employed (ROCE) | -85.21% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -713,039 |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -36,712 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 8,383 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -45.33M |
| Pretax Income | -39.78M |
| Net Income | -40.64M |
| EBITDA | -45.15M |
| EBIT | -45.33M |
| Earnings Per Share (EPS) | -0.09 |
Balance Sheet
The company has 62.20 million in cash and 13.89 million in debt, with a net cash position of 48.31 million.
| Cash & Cash Equivalents | 62.20M |
| Total Debt | 13.89M |
| Net Cash | 48.31M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 51.34M |
| Book Value Per Share | 0.09 |
| Working Capital | 50.10M |
Cash Flow
In the last 12 months, operating cash flow was -32.77 million and capital expenditures -598,844, giving a free cash flow of -33.37 million.
| Operating Cash Flow | -32.77M |
| Capital Expenditures | -598,844 |
| Free Cash Flow | -33.37M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HTTIF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.18% |
| Shareholder Yield | -26.18% |
| Earnings Yield | -21.55% |
| FCF Yield | -17.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |